Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 2
1985 1
1987 1
1992 2
1994 1
1996 1
1997 2
1998 1
2001 1
2004 1
2005 1
2006 1
2012 3
2013 1
2014 1
2015 5
2016 4
2017 1
2018 3
2020 3
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators. Peyvandi F, et al. N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Free article. Clinical Trial.
Cognitive function: holarchy or holacracy?
Birle C, Slavoaca D, Balea M, Livint Popa L, Muresanu I, Stefanescu E, Vacaras V, Dina C, Strilciuc S, Popescu BO, Muresanu DF. Birle C, et al. Among authors: balea m. Neurol Sci. 2021 Jan;42(1):89-99. doi: 10.1007/s10072-020-04737-3. Epub 2020 Oct 18. Neurol Sci. 2021. PMID: 33070201 Review.
Multiple Intestinal Lymphoma.
Mastalier B, Deaconescu V, Elaiah W, Drăghici C, Popp C, Zurac S, Balea M, Tevet M, Botezatu C. Mastalier B, et al. Among authors: balea m. Rom J Intern Med. 2015 Jan-Mar;53(1):73-8. doi: 10.1515/rjim-2015-0010. Rom J Intern Med. 2015. PMID: 26076564 Free article.
VaD - An Integrated Framework for Cognitive Rehabilitation.
Balea M, Muresanu D, Alvarez A, Homberg V, Bajenaru O, Guekht A, Heiss WD, Popa L, Vester J, Muresanu I, Birle C, Slavoaca D. Balea M, et al. CNS Neurol Disord Drug Targets. 2018 Apr 26;17(1):22-33. doi: 10.2174/1871527317666180219164545. CNS Neurol Disord Drug Targets. 2018. PMID: 29468984 Review.
Reading beyond the glance: eye tracking in neurosciences.
Popa L, Selejan O, Scott A, Mureşanu DF, Balea M, Rafila A. Popa L, et al. Among authors: balea m. Neurol Sci. 2015 May;36(5):683-8. doi: 10.1007/s10072-015-2076-6. Epub 2015 Jan 22. Neurol Sci. 2015. PMID: 25604577 Review.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
41 results